Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Head & Neck 3Plasma cell 2Lymphoid 2Gastrointestinal 2Dermatologic 2Other hematologic neoplasm 1Gynecologic 1Genitourinary 1Classical hematology 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Fanconi Anemia 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Whole-Body Irradiation 5Mycophenolic Acid 4Tacrolimus 3Rituximab 3Peripheral Blood Stem Cell Transplantation 3Cyclosporine 3Busulfan 3fludarabine 2apixaban 2Methotrexate 2Melphalan 2Lenalidomide 2Etoposide 2CT-P10 2Biopsy 2Azacitidine 2venetoclax 1thymoglobulin 1merphos 1ivosidenib 1ibrutinib 1edoxaban 1Vorinostat 1Vancomycin 1Thiotepa 1Teicoplanin 1TAK-243 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Afatinib × Classical hematology × 30 days × Clear all
NCT06648096 2026-05-27

AFAN

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 1/2 Recruiting
25 enrolled
Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Fanconi Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡